A carregar...

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-08-01
Colecção:Vaccines
Assuntos:
Acesso em linha:https://www.mdpi.com/2076-393X/8/3/447
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!